treatment medical

Different antivascular endothelial growth factor treatments and regimens and their outcomes in neovascular age-related macular degeneration: a literature review
Paolo Lanzetta, Paul Mitchell, Sebastian Wolf, Daniele Veritti

British Journal of Ophthalmology Dec 2013, 97 (12) 1497-1507; DOI: 10.1136/bjophthalmol-2013-303394
Twenty-four hour efficacy with preservative free tafluprost compared with latanoprost in patients with primary open angle glaucoma or ocular hypertension
Anastasios G P Konstas, Luciano Quaranta, Andreas Katsanos, Ivano Riva, James C Tsai, Theodoros Giannopoulos, Irini C Voudouragkaki, Eleni Paschalinou, Irene Floriani, Anna-Bettina Haidich

British Journal of Ophthalmology Dec 2013, 97 (12) 1510-1515; DOI: 10.1136/bjophthalmol-2012-303026
Intravenous ‘pulse’ methylprednisolone for the treatment of inflammatory cystoid macular oedema
SiehYean Kiew, John V Forrester, Soon-Phaik Chee, Lucia Kuffová

British Journal of Ophthalmology Dec 2012, 96 (12) 1531-1533; DOI: 10.1136/bjophthalmol-2012-301777
Effect of pegaptanib sodium 0.3 mg intravitreal injections (Macugen) in intraocular pressure: posthoc analysis from V.I.S.I.O.N. study
David S Boyer, Mauro Goldbaum, Anita M Leys, Carla Starita, for the V.I.S.I.O.N. Study Group

British Journal of Ophthalmology Nov 2014, 98 (11) 1543-1546; DOI: 10.1136/bjophthalmol-2013-304075
Recovery of plasma vascular endothelial growth factor concentrations during aflibercept loading phase and after the transition to bimonthly treatment for neovascular age-related macular degeneration
Anca B Roald, Hans C D Aass, Morten C Moe

British Journal of Ophthalmology Dec 2015, 99 (12) 1610-1613; DOI: 10.1136/bjophthalmol-2015-306781
Intraretinal cysts are the most relevant prognostic biomarker in neovascular age-related macular degeneration independent of the therapeutic strategy
Markus Ritter, Christian Simader, Matthias Bolz, Gábor G Deák, Ulrike Mayr-Sponer, Ramzi Sayegh, Michael Kundi, Ursula M Schmidt-Erfurth

British Journal of Ophthalmology Dec 2014, 98 (12) 1629-1635; DOI: 10.1136/bjophthalmol-2014-305186
Three-year visual outcome of photodynamic therapy plus intravitreal bevacizumab with or without subtenon triamcinolone acetonide injections for polypoidal choroidal vasculopathy
Tsutomu Sakai, Yasuhiro Ohkuma, Hideo Kohno, Takaaki Hayashi, Akira Watanabe, Hiroshi Tsuneoka

British Journal of Ophthalmology Dec 2014, 98 (12) 1642-1648; DOI: 10.1136/bjophthalmol-2014-305189
Polypoidal choroidal vasculopathy in Caucasian patients with presumed neovascular age-related macular degeneration and poor ranibizumab response
Katja Hatz, Christian Prünte

British Journal of Ophthalmology Feb 2014, 98 (2) 188-194; DOI: 10.1136/bjophthalmol-2013-303444
Clinical features, microbiological profile and treatment outcome of patients with Corynebacterium endophthalmitis: review of a decade from a tertiary eye care centre in southern India
Joveeta Joseph, Khemlal Nirmalkar, Annie Mathai, Savitri Sharma

British Journal of Ophthalmology Feb 2016, 100 (2) 189-194; DOI: 10.1136/bjophthalmol-2015-306910
Two-year outcomes of intravitreal bevacizumab therapy for macular oedema secondary to branch retinal vein occlusion
Taiichi Hikichi, Makoto Higuchi, Takuro Matsushita, Shoko Kosaka, Reiko Matsushita, Kimitaka Takami, Hideo Ohtsuka, Hirokuni Kitamei, Shoko Shioya

British Journal of Ophthalmology Feb 2014, 98 (2) 195-199; DOI: 10.1136/bjophthalmol-2013-303121

Main menu

treatment medical

Pages

Log in using your username and password

Main menu

Log in using your username and password

You are here

treatment medical

Pages